Your browser doesn't support javascript.
loading
Estimating the Risk of Death from COVID-19 in Adult Cancer Patients.
Williams, M; Mi, E; Le Calvez, K; Chen, J; Pakzad-Shahabi, L; Dadhania, S; Wang, J; Ho, A; Rabinowicz, S.
Affiliation
  • Williams M; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: matthew.williams@imperial.ac.uk.
  • Mi E; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Le Calvez K; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Chen J; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, Chi
  • Pakzad-Shahabi L; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Brain Tumour Research Centre, Imperial College London, London, UK.
  • Dadhania S; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Wang J; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Ho A; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Rabinowicz S; Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Clin Oncol (R Coll Radiol) ; 33(3): e172-e179, 2021 03.
Article de En | MEDLINE | ID: mdl-33218850
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Tumeurs Type d'étude: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia / Europa Langue: En Journal: Clin Oncol (R Coll Radiol) Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Tumeurs Type d'étude: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia / Europa Langue: En Journal: Clin Oncol (R Coll Radiol) Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays de publication: Royaume-Uni